Actualeyes Inc.
Records under this name other than the patents Actualeyes Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 8 of 8 · Back to Actualeyes Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,624,053 | Application of Laminin to Corneal Endothelial Cell Culture now held by Aurion Biotech, Inc. In force · High confidence | In force | High confidence | |
| US 10,908,161 | Corneal Endothelial Cell Marker now held by Aurion Biotech, Inc. In force · High confidence | In force | High confidence | |
| 14/369,050 | Normalization of Culture of Corneal Endothelial Cells held by Actualeyes Inc. and Corneagen, Inc. Abandoned Abandoned Dec 13, 2022 | Abandoned | Abandoned Dec 13, 2022 | |
| 17/936,261 | Normalization of Culture of Corneal Endothelial Cells now held by Aurion Biotech, Inc. Abandoned Abandoned Jun 12, 2025 | Abandoned | Abandoned Jun 12, 2025 | |
| 18/708,876 | Cryopreservation Preparation for Corneal Endothelial Cells and Method for Producing Said Cryopreservation Preparation Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/815,522 | Corneal Endothelial Cell Marker now held by Aurion Biotech, Inc. Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 18/852,996 | Corneal Endothelial Cell Preparation Containing No Culture-Derived Component, and Method for Producing Same now held by The Doshisha Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. | |
| 19/232,430 | Normalization of Culture of Corneal Endothelial Cells now held by Aurion Biotech, Inc. Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. |